Russian Direct Investment Fund on Friday said a preliminary laboratory study conducted by the Gamaleya Center has demonstrated that the Sputnik V vaccine and the one-shot Sputnik Light booster were effective against the Omicron variant of Covid-19. Heterologous boosting with Sputnik Light is the solution to increase other vaccines' efficacy, including against Omicron, and extend the booster protection period, RDIF …
The Russian Direct Investment Fund and Gamaleya Center on Wednesday said one-shot Sputnik Light vaccine demonstrates 70 per cent efficacy against infection with the Delta variant of coronavirus during the first three months after vaccination. Gamaleya Center has submitted an article analysing efficacy of Sputnik Light vaccine against the Delta variant to the medRxiv preprint server for health sciences, RDIF …
technology is owned by the Russian Direct Investment Fund, is the only COVID-19 vaccine approved in India that is being manufactured locally from a diversified manufacturing base. Speaking to Frontline, Dr Hemanth Nandigala, managing director of the Hyderabad-based Virchow Biotech Private Limited, one of the Indian Sputnik V contractors, explains the constraints in scaling up capacity quickly. Excerpts from the …
